Amber Hauskins, PA
Physician Assistant · Mesa, AZNPI 1053059923
Payments from drug & device makers
Across 323 payments — averaging $21.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$819
- Sanofi$504
- Regeneron Healthcare Solutions, Inc.$487
- Boehringer Ingelheim$454
- Actelion Pharmaceuticals US, Inc.$369
- plus $3K from 25 others
What the payments were for
- Food & beverage$6,47993%
- Education$4997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 42 | $1,410 |
| GSK | 56 | $819 |
| Sanofi | 28 | $504 |
| Regeneron Healthcare Solutions, Inc. | 21 | $487 |
| Boehringer Ingelheim | 23 | $454 |
| Actelion Pharmaceuticals US, Inc. | 17 | $369 |
| Grifols USA, LLC | 13 | $346 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $286 |
| Mylan Specialty L.p. | 17 | $246 |
| Sanofi-aventis U.S. LLC | 3 | $210 |
| Viatris Specialty LLC | 11 | $200 |
| Verona Pharma, Inc. | 6 | $180 |
| Merck | 9 | $176 |
| Insmed, Inc. | 7 | $176 |
| United Therapeutics Corporation | 3 | $172 |
| Jazz Pharmaceuticals Inc. | 3 | $163 |
| Electromed, Inc. | 17 | $125 |
| ZOLL Respicardia, Inc. | 6 | $124 |
| Baxter Healthcare | 5 | $74 |
| Mallinckrodt Hospital Products Inc. | 3 | $69 |
| Pulmonx Corporation | 3 | $68 |
| Amgen | 3 | $66 |
| Novartis | 4 | $64 |
| Covis Pharma GmbH | 2 | $57 |
| Genentech USA, Inc. | 2 | $38 |
| Bayer | 1 | $22 |
| Abiomed | 1 | $19 |
| Inogen, Inc. | 2 | $17 |
| Oxford Immunotec USA Inc | 1 | $16 |
| Harmony Biosciences LLC | 1 | $13 |
| Itamar Medical Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,978 in reported general payments places this provider in the 95th percentile of 2,888 physician assistant providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 835 | $644,363 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 352 | $287,086 |
| OfevNintedanib Esylate | 11 | $134,571 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 172 | $102,925 |
| Spiriva RespimatTiotropium Bromide | 143 | $94,422 |
| Breo ElliptaFluticasone/Vilanterol | 137 | $77,460 |
| SymbicortBudesonide/Formoterol Fumarate | 256 | $76,110 |
| Dupixent SyringeDupilumab | 16 | $63,415 |
| Dupixent PenDupilumab | 14 | $61,767 |
| Advair HfaFluticasone Propion/Salmeterol | 127 | $49,577 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 98 | $48,328 |
| Arnuity ElliptaFluticasone Furoate | 167 | $44,839 |
| XolairOmalizumab | 13 | $35,326 |
| Spiriva HandihalerTiotropium Bromide | 46 | $31,949 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 1,010 | $24,263 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta, Incruse Ellipta | $819 | $838,5671,307 claims |
| AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere | $1,410 | $386,828653 claims |
| Boehringer IngelheimOfev, Stiolto Respimat, Spiriva Respimat, Combivent Respimat | $454 | $353,716350 claims |
| MerckDulera | $176 | $5,80017 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,888 physician assistant providers in Arizona.
Other physician assistant in Mesa
- Jessica RosenblumMesa$19K
- Katrina McDanielMesa$14K
- Jenna HiltonGilbert$637K
- Kara GoodingScottsdale$625K
- Ginna GranrothScottsdale$211K
- Nicole MaderaGlendale$128K
- Candace RyanGlendale$113K
- Alyssa BoschenPhoenix$86K
- Christopher BeroScottsdale$81K
- Katherine MinorPhoenix$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.